1.Immunophenotyping and DNA analysis of lymphoid leukemic cells by FACScan system.
Young Ho HAHM ; Joung A KANG ; Kyung Eun SONG ; Jang Soo SUH ; Won Kil LEE ; Jay Sik KIM ; Kun Soo LEE ; Ja Hun KOO
Korean Journal of Clinical Pathology 1992;12(4):445-455
No abstract available.
DNA*
;
Immunophenotyping*
2.Hairy cell Leukemia in a Filipino male during the COVID-19 pandemic – report of a rare case
Karmina Vianca A. Viray ; Maribeth Buan Mayo
Philippine Journal of Internal Medicine 2022;60(4):294-297
Hairy cell leukemia (HCL) is a rare, chronic, mature B-cell lymphoproliferative disorder accounting for 2% of all leukemias. In this paper, we would like to present our experience in the management of HCL in a financially limited setting where other diagnostic tests and chemotherapy are unavailable. The case report aims to emphasize the recognition of the distinctive morphology of hairy cells in the peripheral blood in the consideration of the initial diagnosis. A 60-year-old Filipino male was incidentally found to have anemia, thrombocytopenia and an absolute neutrophilic count below 1,000 in a pre-operative clearance for elective herniorrhaphy. Blood smear revealed atypical lymphocytes with hair like cytoplasmic projections. CT-scan of the abdomen showed splenomegaly and prominent paraaortic nodes. Flow cytometry of the bone marrow aspirate was consistent with an involvement of a Mature B cell neoplasm markers CD19, CD20, CD22 and surface immunoglobulin lambda and hairy cell leukemia markers CD11c, CD103 and CD25. He responded to six-weekly sessions of Cladribine with remission of the bone marrow and hematologic parameters. HCL is a rare type of a mature B cell neoplasm characterized by pancytopenia, splenomegaly, bone marrow fibrosis and the presence of atypical lymphoid cells with hairy projections in blood, bone marrow and spleen. Immunophenotyping express CD11c, CD103, CD123, and CD25. BRAF V600E mutation is the disease defining genetic event. Cladribine and Pentostatin are the first line of treatment. Cases of leukemia can be easily overlooked because of the mild derangement in the complete blood count. A meticulous differential review of the atypical lymphocyte, is the first step in the diagnosis of this rare disease.
Leukemia, Hairy Cell
;
Cladribine
;
Immunophenotyping
3.Recent development on flow cytometric immunophenotyping study in multiple myeloma --- review.
Journal of Experimental Hematology 2011;19(4):1083-1086
Multiple myeloma is a common hematological malignancy which is characterized by plasma cell malignancies proliferation and osteolysis destruction. It manifests M-protein, bone destruction, anemia, renal function impairment and immune function abnormality. In recent years, researchers have known that flow cytometric immunophenotyping is valuable in diagnosis, therapy, prognosis and minimal residual disease detection of multiple myeloma. The review summarizes the development of flow cytometric immunophenotyping in multiple myeloma, including application of flow cytometry in multiple myeloma and immunophenotypic features of flow cytometric analysis in multiple myeloma.
Flow Cytometry
;
Humans
;
Immunophenotyping
;
Multiple Myeloma
;
immunology
4.One case report of splenectomy for T large granular lymphocytic leukemia.
Yuan Yuan XIONG ; Chang Wei YUAN ; Li Na ZHANG ; Qing Lan ZHANG ; Gang Ping LI ; Hu ZHOU ; Jing ZHANG ; Xin Jian LIU ; Xing Chen LIU ; Ming Hui LI ; Ke Shu ZHOU ; Fang Fang YUAN ; Qing Song YIN ; Xu Dong WEI ; Yong Ping SONG
Chinese Journal of Hematology 2019;40(4):339-339
5.Multiparameter Flow Cytometry: Advances in High Resolution Analysis.
Erika A O'DONNELL ; David N ERNST ; Ravi HINGORANI
Immune Network 2013;13(2):43-54
Over the past 40 years, flow cytometry has emerged as a leading, application-rich technology that supports high-resolution characterization of individual cells which function in complex cellular networks such as the immune system. This brief overview highlights advances in multiparameter flow cytometric technologies and reagent applications for characterization and functional analysis of cells modulating the immune network. These advances significantly support high-throughput and high-content analyses and enable an integrated understanding of the cellular and molecular interactions that underlie complex biological systems.
Antibodies
;
Flow Cytometry
;
Fluorescent Dyes
;
Immune System
;
Immunophenotyping
6.Role of flow cytometric immunophenotyping in diagnosis of myelodysplastic syndromes--review.
Journal of Experimental Hematology 2008;16(6):1477-1481
Bone marrow morphology and karyotyping are effective ways to diagnose myelodysplastic syndromes. However, there are still many patients without these two abnormalities. Recently, there are considerable amount of evidence showing that flow cytometric immunophenotyping is a good approach to detect the abnormal differentiation and maturation of different cell lines and maturation stages of bone marrow cells in MDS patients. The highly reproducible results allow to distinguish MDS from other non-clonal hematocytopenia disorders and have a diagnostic advantage especially in case of low-risk MDS. Meanwhile, it showed a good correlation with the morphology and karyotyping, and with the International Prognostic Scoring System (IPSS) playing a prognostic role. This article reviewed recent advances of research in this field such as the application of FCM in MDS detection, the correlation of FCM parameters with morphologic and cytogenetic diagnosis of MDS as well as the relationship of parameters with typing and prognosis of MDS and so on.
Flow Cytometry
;
methods
;
Humans
;
Immunophenotyping
;
Myelodysplastic Syndromes
;
diagnosis
;
immunology
7.New advance of research on prognostic factors in myelodysplastic syndrome--review.
Journal of Experimental Hematology 2008;16(6):1465-1472
Myelodysplastic syndrome (MDS) represents a heterogeneous group of myeloid malignancies characterized by abnormal differentiation and maturation of myeloid cells, bone marrow failure, and a genetic instability with enhanced risk to transform to acute myeloid leukemia. Many factors influence on the prognosis of MDS. The prognosis of MDS subtypes has been changing with the application of World Health Organization (WHO) classification and different new prognostic scoring system, the technology development of cytogenetics and flow cytometry, and the advent of new drugs. A series of recent literatures are summarized on different prognostic factors of MDS. In this review, the controversy in application of WHO classification, MDS prognosis in relation with prognostic scoring system, cytogenetics, immunophenotype and therapeutics were discussed.
Humans
;
Immunophenotyping
;
Myelodysplastic Syndromes
;
classification
;
diagnosis
;
genetics
;
Prognosis
8.CD8+ Lymphomatoid Papulosis.
Annals of Dermatology 2011;23(1):104-107
Lymphomatoid papulosis (LyP) is defined as a histologically malignant, but clinically benign condition. It can appear as erythematous pink to purple papules or nodules. Immunophenotyping studies of the lymphomatoid papulosis lesions have shown a predominance of a CD4 expression and negativity for CD8. However, a positive CD8 expression has rarely been reported for LyP. Herein we report on a case of CD8 positive lymphomatoid papulosis in a 43-year-old man. The patient presented with erythematous, asymptomatic papules on the left axilla and thigh. Histopathologically, there was a wedge-shaped infiltrate composed of a mixture of various cell types, including lymphocytes, histiocytes, neutrophils and large atypical lymphoid cells. Immunophenotyping revealed the neoplastic cells were positive for CD3, CD8 and CD30 and they were negative for CD4, CD20 and CD56.
Adult
;
Axilla
;
Histiocytes
;
Humans
;
Immunophenotyping
;
Lymphocytes
;
Lymphomatoid Papulosis
;
Neutrophils
;
Thigh
9.CD4⁺/CD8⁻ T- cell large granular lymphocytic leukemia: one case report and literatures reviews.
Yang LI ; Zhijie WU ; Jianping LI ; Yuan LI ; Guangxin PENG ; Lin SONG ; Wenrui YANG ; Kang ZHOU ; Li ZHANG ; Liping JING ; Fengkui ZHANG
Chinese Journal of Hematology 2015;36(9):739-742
OBJECTIVEPresenting the clinical features of one patient with CD4⁺/CD8⁻ T-cell large granular lymphocytic leukemia, to improve the understanding of the disease.
METHODSClinical data of one patient hospitalized for skin rush and leukocytosis were analyzed, and the related literatures were reviewed.
RESULTSThe patient was hospitalized for skin rush and leukocytosis. Routine blood test showed remarkable elevated white blood cell counts and mild anemia. Subsequent hematological examination led to a diagnosis of T- cell large granular lymphocytic leukemia with CD4⁺/CD8⁻ immunophenontype.
CONCLUSIONCD3⁺/CD4⁺/CD8⁻ T- cell large granular lymphocytic leukemia is a kind of variant subtype, and is relatively rare, it has different clinical features with classic CD3⁺/CD4⁻/CD8⁺/TCRαβ⁺T- cell large granular lymphocytic leukemia, so differentiating diagnosis is of great importance.
Anemia ; Humans ; Immunophenotyping ; Leukemia, Large Granular Lymphocytic ; classification ; diagnosis
10.Diagnostic Value of Cytomorphology in Acute Leukemia.
Ping LIN ; Ruo-Teng XIE ; Ya-Lan ZHANG ; Xue-Ya ZHANG
Journal of Experimental Hematology 2019;27(6):1806-1811
OBJECTIVE:
To investigate the diagnostic value of cytomorphology (including cytochemical staining) in newly diagnosed acute leukemia, so as to improve the importance of cytomorphology.
METHODS:
The clinical data of 119 cases of acute leukemia diagnosed in our hospital from April 2016 to June 2018 were analyzed retrospectively. According to morphologic and immunological typing, accordance rate to final diagnosis was compared.
RESULTS:
The diagnostic accordance rate of simple morphological typing was 76.5%, and the diagnostic accordance rate of simple immunological typing was 79.8%, the difference of diagnostic coincidence rate was not significant between the two groups of acute leukemia.
CONCLUSION
Cytomorphology is the cornerstone of the diagnosis of acute leukemia, it has similar value to immunological classification in the diagnosis of leukemia and should pay enough attention. MICM comprehensive diagnosis can improve the final diagnosis rate, showing a guidance significance for the treatment and prognosis of patients with acute leukemia.
Humans
;
Immunophenotyping
;
Leukemia, Myeloid, Acute
;
Prognosis
;
Retrospective Studies